Common neural fingerprint linked to five psychedelics, study suggests
A multinational reanalysis of 11 datasets (267 participants, 519 brain scans) across five psychedelics—psilocybin, LSD, mescaline, DMT and ayahuasca—identified a shared neural fingerprint: increased cross-network communication and selective reductions within certain networks across cortical and subcortical regions, suggesting a flattening of the brain's hierarchy. The pattern was most similar for psilocybin and LSD. While promising for understanding psychedelics and potential therapies, the study emphasizes the need for standardized, larger trials and notes that existing datasets used varied methods and doses.
